NCT03748264已完成不适用
User Preference/Validation Evaluation of the New Philips Respironics Positive Airway Pressure Application
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 62
- 试验地点
- 10
- 主要终点
- User Preference of the New Philips Respironics Positive Airway Pressure Application as Measured by the Attitudes Toward Use Questionnaire
研究概览
简要总结
This pilot study is intended to evaluate the acceptance and performance of the DreamMapper application and the Therapist Assist educational tool in naïve patients with Obstructive Sleep Apnea who have been prescribed Positive Airway Pressure therapy. A total of approximately 60 naïve participants will be recruited.
详细描述
This is a randomized prospective trial designed to obtain subjective and objective feedback in a home use environment with participants using a Philips Respironics System One Positive Airway Pressure device. Participants will be randomly assigned to one of three methods of therapy introduction and monitoring:
- Group 1: The first group, the control condition, participants will receive the sites therapy initiation standard of care for setting up and educating the participants on their Obstructive Sleep Apnea, mask, and device information. This group will use a wireless modem that is attached to the Positive Airway Pressure device and uploads adherence and other therapy information daily to a secured database (Encore Anywhere). With this method, therapy information is not directly available to the participant. Therapy information is available continuously to site staff personnel in the standard care arm.
- Group 2: The second group will receive the site's therapy initiation standard of care for setting up and educating the participants on their Obstructive Sleep Apnea, mask, and device information. Participants in this group will also download the DreamMapper application on their iPhone or Android smart phone. Therapy information and educational material will be available continuously to the participant with DreamMapper through the application. Study personnel will have access to adherence and therapy information continuously as well.
- Group 3: The third group will not receive the site's therapy initiation standard of care but will review the Therapist Assist automated educational material on Obstructive Sleep Apnea, and their Philips Respironics mask. and DreamMapper. These participants will download the DreamMapper application onto their iPhone or Android smart phone. Therapy information and educational material will be available continuously to the participant with DreamMapper. Study personnel will have access to adherence and therapy information continuously as well.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 21 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age 21-75
- •Diagnosis of Obstructive Sleep Apnea (OSA) with an Apnea Hypopnea Index (AHI) of at least 15 events/hour of sleep and a Central Apnea Index (CAI) ≤ 5 events /hour or ≤ 50% of the AHI.
- •Newly diagnosed and Continuous Positive Airway Pressure (CPAP) Naïve.
- •Currently owns and uses apps on an Android or iPhone smart phone.
- •Willing to undergo an attended in lab Polysomnography (PSG)
- •Willing and able to provide informed consent.
- •Speaks and reads English as their primary language.
排除标准
- •Presence of poorly managed or unstable major medical or psychiatric conditions that would interfere with the demands of the study, adherence to positive airway pressure, or the ability to complete the study. For example, unstable congestive heart failure, chronic lung disease with daytime hypercapnia, neuromuscular disease, psychiatric disease, cancer, or chronic renal failure.
- •Participants who are unwilling to try Positive Airway Pressure (PAP) therapy.
- •Participants currently prescribed oxygen therapy (as needed, nocturnal, or continuous).
- •Participants with previously diagnosed respiratory failure or respiratory insufficiency.
- •Recent surgery of the upper airway, noise, sinus, or eyes.
- •Participant is prescribed a BiPAP device
- •Commercial Drivers
- •Shift workers
- •Participants with untreated periodic limb movement syndrome, or restless legs syndrome (PLM Arousal Index > 15).
- •Participants with untreated known diagnosis of Insomnia (score of 15-21(moderate severity) per Insomnia Severity Index (ISI) )
- •Known diagnosis of bipolar disorder
- •Participant with unstable anti- depressant medication (not stable for 3 months)
结局指标
主要结局
User Preference of the New Philips Respironics Positive Airway Pressure Application as Measured by the Attitudes Toward Use Questionnaire
时间窗: 90 days
Participants will complete the Attitudes Toward Use Questionnaire (0 to 10 scale) to determine user preference of the New Philips Respironics Positive Airway Pressure Application. The higher the value the higher participant confidence.
次要结局
- Treatment Outcomes - Epworth Sleepiness Scale(90 days)
- Overall Economic Cost Saving(90 days)
- Adherence(90 days)
- Patient Interactions(90 days)
- Mask Refits(90 days)
- Treatment Outcomes - Functional Outcomes of Sleep Questionnaire (FOSQ)(90 days)
- Site Economic Savings Assessed by Number of Phone Calls.(90 days)
研究者
研究点 (10)
Loading locations...
相似试验
已完成
不适用
The PortionSize Smartphone App Pilot (PS Pilot)Dietary HabitsNCT04494971Pennington Biomedical Research Center15
已完成
不适用
Feasibility of a Novel Exergame-Based Training Concept for Older Adults With Mild Neurocognitive DisorderMild Neurocognitive DisorderNCT04996654Eling DeBruin18
已完成
不适用
Development and evaluation of application to improve non-motor symptoms of people with Parkinson's Disease: a pilot studyDiseases of the nervous systemKCT0005196Yonsei University22
已完成
不适用
Wearable Grasping Neuroprosthesis Used at Home in Subjects With Post-stroke HemiparesisStroke, RehabilitationNCT05625113University Hospital, Toulouse6
已完成
不适用
An Evaluation of the Families Addressing Cancer Together (FACT) InterventionNeoplasmsParentingCommunicationParentsParent-Child RelationsCancerNCT04342871UNC Lineberger Comprehensive Cancer Center53